Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes
Abstract Diabetes mellitus is a major risk factor for acute kidney injury (AKI). Here, we hypothesized that suppression of autophagic response underlies aggravation of renal ischemia/reperfusion (I/R) injury by type 2 diabetes mellitus (T2DM). In OLETF, a rat model of T2DM, and its non-diabetic cont...
Guardado en:
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/63a54ac622c841ca87fa8f2d60c4ecd4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:63a54ac622c841ca87fa8f2d60c4ecd4 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:63a54ac622c841ca87fa8f2d60c4ecd42021-12-02T12:32:45ZSuppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes10.1038/s41598-017-05667-52045-2322https://doaj.org/article/63a54ac622c841ca87fa8f2d60c4ecd42017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05667-5https://doaj.org/toc/2045-2322Abstract Diabetes mellitus is a major risk factor for acute kidney injury (AKI). Here, we hypothesized that suppression of autophagic response underlies aggravation of renal ischemia/reperfusion (I/R) injury by type 2 diabetes mellitus (T2DM). In OLETF, a rat model of T2DM, and its non-diabetic control, LETO, AKI was induced by unilateral nephrectomy and 30-min occlusion and 24-h reperfusion of the renal artery in the contralateral kidney. Levels of serum creatinine and blood urea nitrogen and tubular injury score after I/R were significantly higher in OLETF than in LETO. Administration of chloroquine, a widely used autophagy inhibitor, aggravated I/R-induced renal injury in LETO, but not in OLETF. In contrast to LETO, OLETF exhibited no increase in autophagosomes in the proximal tubules after I/R. Immunoblotting showed that I/R activated the AMPK/ULK1 pathway in LETO but not in OLETF, and mTORC1 activation after I/R was enhanced in OLETF. Treatment of OLETF with rapamycin, an mTORC1 inhibitor, partially restored autophagic activation in response to I/R and significantly attenuated I/R-induced renal injury. Collectively, these findings indicate that suppressed autophagic activation in proximal tubules by impaired AMPK/ULK1 signaling and upregulated mTORC1 activation underlies T2DM-induced worsening of renal I/R injury.Shingo MuratsubakiAtsushi KunoMasaya TannoTakayuki MikiToshiyuki YanoHirohito SugawaraSatoru ShibataKoki AbeSatoko IshikawaKouhei OhnoYukishige KimuraYuki TatekoshiKei NakataWataru OhwadaMasashi MizunoTetsuji MiuraNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-13 (2017) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Shingo Muratsubaki Atsushi Kuno Masaya Tanno Takayuki Miki Toshiyuki Yano Hirohito Sugawara Satoru Shibata Koki Abe Satoko Ishikawa Kouhei Ohno Yukishige Kimura Yuki Tatekoshi Kei Nakata Wataru Ohwada Masashi Mizuno Tetsuji Miura Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes |
description |
Abstract Diabetes mellitus is a major risk factor for acute kidney injury (AKI). Here, we hypothesized that suppression of autophagic response underlies aggravation of renal ischemia/reperfusion (I/R) injury by type 2 diabetes mellitus (T2DM). In OLETF, a rat model of T2DM, and its non-diabetic control, LETO, AKI was induced by unilateral nephrectomy and 30-min occlusion and 24-h reperfusion of the renal artery in the contralateral kidney. Levels of serum creatinine and blood urea nitrogen and tubular injury score after I/R were significantly higher in OLETF than in LETO. Administration of chloroquine, a widely used autophagy inhibitor, aggravated I/R-induced renal injury in LETO, but not in OLETF. In contrast to LETO, OLETF exhibited no increase in autophagosomes in the proximal tubules after I/R. Immunoblotting showed that I/R activated the AMPK/ULK1 pathway in LETO but not in OLETF, and mTORC1 activation after I/R was enhanced in OLETF. Treatment of OLETF with rapamycin, an mTORC1 inhibitor, partially restored autophagic activation in response to I/R and significantly attenuated I/R-induced renal injury. Collectively, these findings indicate that suppressed autophagic activation in proximal tubules by impaired AMPK/ULK1 signaling and upregulated mTORC1 activation underlies T2DM-induced worsening of renal I/R injury. |
format |
article |
author |
Shingo Muratsubaki Atsushi Kuno Masaya Tanno Takayuki Miki Toshiyuki Yano Hirohito Sugawara Satoru Shibata Koki Abe Satoko Ishikawa Kouhei Ohno Yukishige Kimura Yuki Tatekoshi Kei Nakata Wataru Ohwada Masashi Mizuno Tetsuji Miura |
author_facet |
Shingo Muratsubaki Atsushi Kuno Masaya Tanno Takayuki Miki Toshiyuki Yano Hirohito Sugawara Satoru Shibata Koki Abe Satoko Ishikawa Kouhei Ohno Yukishige Kimura Yuki Tatekoshi Kei Nakata Wataru Ohwada Masashi Mizuno Tetsuji Miura |
author_sort |
Shingo Muratsubaki |
title |
Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes |
title_short |
Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes |
title_full |
Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes |
title_fullStr |
Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes |
title_full_unstemmed |
Suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes |
title_sort |
suppressed autophagic response underlies augmentation of renal ischemia/reperfusion injury by type 2 diabetes |
publisher |
Nature Portfolio |
publishDate |
2017 |
url |
https://doaj.org/article/63a54ac622c841ca87fa8f2d60c4ecd4 |
work_keys_str_mv |
AT shingomuratsubaki suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT atsushikuno suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT masayatanno suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT takayukimiki suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT toshiyukiyano suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT hirohitosugawara suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT satorushibata suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT kokiabe suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT satokoishikawa suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT kouheiohno suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT yukishigekimura suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT yukitatekoshi suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT keinakata suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT wataruohwada suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT masashimizuno suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes AT tetsujimiura suppressedautophagicresponseunderliesaugmentationofrenalischemiareperfusioninjurybytype2diabetes |
_version_ |
1718393981594763264 |